US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 22, 2022 (4 years ago)

Polyhexamethylene Biguanide 0.2mg/Ml

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

What was recalled

POLYHEXAMETHYLENE BIGUANIDE 0.2MG/ML (0.2%) (10ML DROPTAINER) OPTH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

Recalling firm
Pharmacy Innovations
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0232-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methyl recalls

See all
Class II · Moderate risk Ongoing

Carton Label: MAJOR

Reason Subpotent Drug

The Harvard Drug Group LLC NDC 0904-7282-10 D-0609-2026
Class III · Low risk Ongoing

Focalin XR

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

Sandoz Inc D-0608-2026
Class II · Moderate risk Ongoing

methylprednisolone tablets

Reason Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.

Greenstone Llc NDC 59762-4440-2 D-0299-2026
Class II · Moderate risk Ongoing

Methylene Blue for Injection

Reason Lack of Assurance of Sterility

GenoGenix LLC D-0063-2026